Contact this trialFirst, we need to learn more about you.
Corticosteroid
Selinexor + Ruxolitinib + Methylprednisolone for Multiple Myeloma
Recruiting1 awardPhase 1
West Hollywood, California
This trial tested a new drug called Selinexor, which works by blocking a protein called XPO1. This causes tumor suppressor proteins to build up and stops the production of proteins that help
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service